Subtype
Benign Skin Epithelial Neoplasm
CI-CAN-00000546Explore in graph →
Non-malignant10 active trials
- NCIt
- C7341
Loading cancer entity…
Subtype
CI-CAN-00000546Explore in graph →
Clinical trials
60 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT07806617 | Intralesional Gardasil-9 for the Treatment of Recalcitrant Warts | active not recruiting | Phase 2 | 55 | Rush University Medical CenterOTHER | 1 | Sep 15, 2026 | clinicaltrials |
| NCT07805798 | Urinary Bladder Matrix (UBM) Registry | not yet recruiting | — | 300 | Integra LifeSciences CorporationINDUSTRY | 0 | Sep 4, 2026 | clinicaltrials |
| Cantharidin Application in Patients With Common Warts (Verruca Vulgaris) (COVE-3)(COVE-3) |
| recruiting |
| Phase 3 |
| 300 |
| Verrica Pharmaceuticals Inc.INDUSTRY |
| 2 |
| Sep 3, 2026 |
| clinicaltrials |
| NCT03977753 | Randomized, Placebo-controlled, Double Blind Study to Evaluate the Efficacy of 2LVERU®JUNIOR and 2LVERU® on the Treatment of Warts(EVAsION) | recruiting | Phase 4 | 162 | Labo'LifeINDUSTRY | 1 | Aug 31, 2026 | clinicaltrials |
| NCT07301424 | Subcutaneous Blinatumomab Plus Ponatinib for BCR-ABL+ B-ALL | not yet recruiting | Phase 2 | 80 | University of AlbertaOTHER | 1 | Aug 12, 2026 | clinicaltrials |
| NCT07448844 | Intralesional Therapies For Cutaneous Viral Warts: A Comparative Analysis Of Vitamin D3 And Acyclovir | recruiting | Phase 4 | 40 | Riphah International UniversityOTHER | 1 | Aug 7, 2026 | clinicaltrials |
| NCT07457918 | Long-Term Follow-up Study of Cantharidin (YCANTH [VP-102/TO-208]) in Patients With Common Warts (Verruca Vulgaris)(COVE-4) | recruiting | Phase 3 | 600 | Verrica Pharmaceuticals Inc.INDUSTRY | 1 | May 5, 2026 | clinicaltrials |
| NCT07543926 | New Treatment of Common Wart | not yet recruiting | N/A | 70 | Sohag UniversityOTHER | 1 | Apr 22, 2026 | clinicaltrials |
| NCT05937672 | Cold Atmospheric Plasma Device Extension Study | terminated | Phase 3 | 60 | Medical University of South CarolinaOTHER | 1 | Apr 3, 2026 | clinicaltrials |
| NCT07441538 | Optimizing the Timing for Facial Surgical Dressing Removal | completed | N/A | 144 | Union Hospital, Tongji Medical College, Huazhong University of Science and TechnologyOTHER | 1 | Mar 3, 2026 | clinicaltrials |
| NCT07428941 | Evaluating an Artificial Intelligence Tool to Help Primary Care Doctors Diagnose Skin Conditions.(LegitHealth PH) | completed | — | 9 | AI Labs Group S.LINDUSTRY | 1 | Feb 24, 2026 | clinicaltrials |
| NCT07384299 | Impact of Skin Type on Wonud Healing and Scarring Following Facial Skin Surgery | completed | — | 173 | Union Hospital, Tongji Medical College, Huazhong University of Science and TechnologyOTHER | 1 | Feb 3, 2026 | clinicaltrials |
| NCT07246590 | Cantharidin Application in Patients With Common Warts (Verruca Vulgaris) (COVE-2)(COVE-2) | recruiting | Phase 3 | 300 | Verrica Pharmaceuticals Inc.INDUSTRY | 1 | Jan 21, 2026 | clinicaltrials |
| NCT07334600 | Effect of 1% Andaliman Fruit Extract Cream on Facial Seborrheic Keratosis(ANDAL-SK) | completed | N/A | 40 | Universitas Sumatera UtaraOTHER | 1 | Jan 12, 2026 | clinicaltrials |
| NCT05889845 | Candin for the Treatment of Common Warts | completed | Phase 3 | 330 | Nielsen BioSciences, Inc.INDUSTRY | 1 | Sep 5, 2025 | clinicaltrials |
| NCT07152041 | Newly-diagnosed Pediatric Ph-positive B-ALL Protocol(CAMS-Ph+ B-ALL) | recruiting | Phase 3 | 150 | Institute of Hematology & Blood Diseases Hospital, ChinaOTHER | 2 | Sep 3, 2025 | clinicaltrials |
| NCT07021495 | SKIN Disease Profiling by an Exploratory, pRospective, Biomarker Study in dermatoloGY Practice (SKINERGY)(SKINERGY) | recruiting | — | 840 | Leiden University Medical CenterOTHER | 1 | Aug 19, 2025 | clinicaltrials |
| NCT07095348 | Relationship Between Serum Xanthine Oxidase Levels and Seborrheic Keratosis(SK-XO) | completed | — | 80 | Sri Nauli Dewi LubisOTHER | 1 | Jul 31, 2025 | clinicaltrials |
| NCT05294640 | Bacteriostatic Saline as a Local Anesthetic in Minor Eyelid Procedures | completed | Phase 4 | 95 | University of California, San FranciscoOTHER | 1 | Jul 8, 2025 | clinicaltrials |
| NCT05799157 | Safety and Efficacy of VDMN-21 Patch in Subjects With Common Warts | completed | Phase 2 | 153 | Veradermics, Inc.INDUSTRY | 1 | May 8, 2025 | clinicaltrials |
| NCT06214559 | Evaluate the Effectiveness and the Safety of a Medical Device in the Treatment of Common Warts and Plantar Warts. | completed | N/A | 33 | Swiss Footcare Laboratories - Poderm ProfessionalINDUSTRY | 1 | Mar 5, 2025 | clinicaltrials |
| NCT00715819 | Use of Otoscope as a Non-invasive Tool for Diagnosis of Pilomatricoma | completed | — | 4 | Stanford UniversityOTHER | 1 | Dec 27, 2024 | clinicaltrials |
| NCT06749665 | Sclerotherapy and Candida Antigen in Treatment of Common Warts | not yet recruiting | N/A | 75 | Sohag UniversityOTHER | 1 | Dec 27, 2024 | clinicaltrials |
| NCT03487549 | Cantharidin and Occlusion in Verruca Epithelium(COVE-1) | completed | Phase 2 | 56 | Verrica Pharmaceuticals Inc.INDUSTRY | 1 | Nov 27, 2024 | clinicaltrials |
| NCT05896215 | OM202JP Clinical Study of KNP2002 | completed | Phase 2 | 159 | KinoPharma Inc.INDUSTRY | 1 | Sep 27, 2024 | clinicaltrials |
| NCT06046144 | Comparison of 3 in Vivo Microscopic Imaging Techniques for the Diagnosis of Pigmented Tumors(Micro3) | completed | — | 161 | Centre Hospitalier Universitaire de Saint EtienneOTHER | 1 | Jun 24, 2024 | clinicaltrials |
| NCT04229277 | Fast Track Diagnosis of Skin Cancer by Advanced Imaging | completed | N/A | 41 | University Hospital Bispebjerg and FrederiksbergOTHER | 1 | Jun 20, 2024 | clinicaltrials |
| NCT05877313 | Nitric Oxide Releasing Solution (NORS) For The Treatment Of Human Papillomavirus(HPV) Verrucae Plantaris (Plantar Warts) | completed | Phase 2 | 20 | Sanotize Research and Development corp.INDUSTRY | 1 | Apr 17, 2024 | clinicaltrials |
| NCT05070754 | Cold Atmospheric Plasma Device for Pediatric Molluscum and Verruca | completed | Phase 4 | 17 | Medical University of South CarolinaOTHER | 1 | Apr 5, 2024 | clinicaltrials |
| NCT04249115 | Nano-Pulse Stimulation (NPS) in Seborrheic Keratosis Optimization Study | terminated | N/A | 175 | Pulse Biosciences, Inc.INDUSTRY | 1 | Oct 30, 2023 | clinicaltrials |
| NCT01796795 | Efficacy and Safety of SR-T100 Gel in Common Warts (CW) Patients | suspended | Phase 2 | 102 | G&E Herbal Biotechnology Co., LTDINDUSTRY | 0 | Sep 14, 2023 | clinicaltrials |
| NCT04793529 | Is Involucrin Has a Role in Verruca Vulgaris? A Clinical and Immunohistochemical Study | completed | N/A | 60 | Benha UniversityOTHER | 1 | Jul 27, 2023 | clinicaltrials |
| NCT04688749 | Use of Electrical Impedance Spectroscopy (EIS) for Early Diagnosis of Skin Damage(DermaSense) | terminated | — | 50 | Aristotle University Of ThessalonikiOTHER | 1 | Jul 25, 2023 | clinicaltrials |
| NCT04823845 | Plantar Wart Treatment Using Adapalene Gel | withdrawn | Early Phase 1 | 0 | University of LouisvilleOTHER | 0 | Apr 13, 2023 | clinicaltrials |
| NCT05115669 | Safety & Effectiveness of Wortie Freeze Plus in Common and Plantar Warts | completed | N/A | 50 | Karo Pharma ABINDUSTRY | 1 | Feb 21, 2023 | clinicaltrials |
| NCT04932746 | The Effect of Dexmedetomidine on Oxygen During One Lung Ventilation in Pediatric Surgery.(RCT) | completed | N/A | 110 | Damascus UniversityOTHER | 1 | Feb 17, 2023 | clinicaltrials |
| NCT00540566 | Optical Biopsy of Human Skin in Conjunction With Laser Treatment | completed | — | 113 | University of California, IrvineOTHER | 1 | Oct 20, 2022 | clinicaltrials |
| NCT05488860 | Piezoelectric Drived Microneedling in Treating Refractory Skin Diseases | unknown | N/A | 20 | Xiangya Hospital of Central South UniversityOTHER | 1 | Aug 5, 2022 | clinicaltrials |
| NCT05409365 | Assessment of Squamous Cell Carcinoma antigen2 in Verruca Vulgaris | unknown | — | 50 | Sohag UniversityOTHER | 1 | Jun 10, 2022 | clinicaltrials |
| NCT02759900 | Using a Cold Atmospheric Plasma Device to Treat Skin Disorders | unknown | N/A | 100 | The Skin Center Dermatology GroupINDUSTRY | 1 | Apr 12, 2022 | clinicaltrials |
| NCT04620785 | Photodynamic Therapy in Treatment of Verrucae | unknown | N/A | 80 | Alexandria UniversityOTHER | 1 | Jul 26, 2021 | clinicaltrials |
| NCT01131325 | Study of Nilotinib in Ph+ CML-CP Patients With Low Imatinib Trough Plasma Concentrations(MACS1148) | terminated | Phase 4 | 3 | Novartis PharmaceuticalsINDUSTRY | 1 | May 20, 2021 | clinicaltrials |
| NCT03812510 | Safety Study of A-101 Topical Solution for the Treatment of Common Warts | completed | Phase 3 | 426 | Aclaris Therapeutics, Inc.INDUSTRY | 1 | Nov 23, 2020 | clinicaltrials |
| NCT03691831 | A Study of A-101 Topical Solution for the Treatment of Common Warts | completed | Phase 3 | 502 | Aclaris Therapeutics, Inc.INDUSTRY | 1 | Oct 27, 2020 | clinicaltrials |
| NCT03687372 | Study of A-101 Topical Solution for the Treatment of Common Warts | completed | Phase 3 | 503 | Aclaris Therapeutics, Inc.INDUSTRY | 1 | Oct 5, 2020 | clinicaltrials |
| NCT03183765 | Intralesional Measles, Mumps, Rubella (MMR) Vaccine Versus Cryotherapy in Treatment of Multiple Common and Planter Warts | completed | Phase 4 | 48 | Assiut UniversityOTHER | 1 | Jun 16, 2020 | clinicaltrials |
| NCT04288817 | Efficacy of Cryotherapy Combined With Intralesional Tuberculin PPD Versus Intralesional Tuberculin PPD in Treatment of Multiple Common Warts | unknown | Phase 3 | 40 | Assiut UniversityOTHER | 0 | Feb 28, 2020 | clinicaltrials |
| NCT03210337 | A Phase2 of A-101 Topical Solution in Subjects With Common Warts | completed | Phase 2 | 157 | Aclaris Therapeutics, Inc.INDUSTRY | 1 | May 1, 2019 | clinicaltrials |
| NCT03278028 | A Study of A-101 Topical Solution Administered Twice a Week in Subjects With Common Warts | completed | Phase 2 | 159 | Aclaris Therapeutics, Inc.INDUSTRY | 1 | Apr 9, 2019 | clinicaltrials |
| NCT01609530 | Pulsed 1064nm Nd:YAG in the Treatment of Verruca Vulgaris Versus Conventional Therapy With Liquid Nitrogen Cryotherapy | terminated | N/A | 31 | Trinity Health MichiganOTHER | 1 | Mar 22, 2018 | clinicaltrials |
Data updated 14 days agoSource updated Sep 15, 2026source: clinicaltrials